Independent clinical trial SMO Panthera Biopartners has appointed Chris Dodd as Executive VP of Business Development – Oncology and CNS. Dodd joins Panthera from Accelerated Enrolment Solutions.
Dodd will specialize in the development of Panthera’s CNS and Oncology Expertise. Prior to joining AES he held senior management positions at Medtronic, Beckton Dickinson and Bracket Global now part of Signant Health. Dodd has a BSc in Bio-medicine from Leeds.
Dodd joins the Panthera management team which includes Chairman, Chief Financial Officer and co-founder Professor John Lyon, who was previously a global executive in CRO Covance; Medical Director and co-founder Dr. Ian Smith, who previously founded Synexus; CEO Stuart Young who was previously UK Country Manager of Synexus and Jane Restorick, Chief Commercial Officer, who was most recently Chief Operating Officer and Chief Patient Officer at Synexus.
“We are continuing to build a world class team and are really delighted that Chris has chosen to join us. Chris has a proven record of working with clients across the world and will be leading the business development for our growing network of specialist services. This is an area highlighted by our clients in the industry where there is a real need for professionally run sites,” Chairman John Lyon said.